Drostanolone Enanthate Masteron CAS 13425-31-5 521-12-0 58-19-5
- Nor Norq
- 27/12/2024 07:20
Office
-
Company name
Drostanolone Enanthate Masteron CAS 13425-31-5 521-12-0 58-19-5
-
Workspace
Journalism, Media
-
Schedule
Full time
-
Education
Secondary
-
Experience
Common Name Drostanolone Enanthate
CAS Number 13425-31-5
Molecular Weight 416.637
Density 1.0±0.1 g/cm3
Boiling Point 497.0±45.0 °C at 760 mmHg
Molecular Formula C27H44O3
Flash Point 209.4±28.8 °C
Density 1.0±0.1 g/cm3
Boiling Point 497.0±45.0 °C at 760 mmHg
Molecular Formula C27H44O3
Molecular Weight 416.637
Flash Point 209.4±28.8 °C
Exact Mass 416.329041
LogP 7.80
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.516
Storage condition 2-8°C
Drostanolone enanthate is an anabolic steroid that belongs to the class of androgenic hormones. It is a synthetic derivative of dihydrotestosterone (DHT) and has potent anticancer activity against prostate carcinoma cells. Drostanolone enanthate inhibits the growth of cancer cells by binding to the androgen receptor, which is located in the cytoplasm. This causes a conformational change in the receptor that prevents it from interacting with DNA. Drostanolone enanthate also inhibits fatty acid synthesis and microbial biotransformation, which may have anticancer effects.
-
Sex
-
Age
-
Description
-
Common Name Drostanolone Enanthate
CAS Number 13425-31-5
Molecular Weight 416.637
Density 1.0±0.1 g/cm3
Boiling Point 497.0±45.0 °C at 760 mmHg
Molecular Formula C27H44O3
Flash Point 209.4±28.8 °C
Density 1.0±0.1 g/cm3
Boiling Point 497.0±45.0 °C at 760 mmHg
Molecular Formula C27H44O3
Molecular Weight 416.637
Flash Point 209.4±28.8 °C
Exact Mass 416.329041
LogP 7.80
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.516
Storage condition 2-8°C
Drostanolone enanthate is an anabolic steroid that belongs to the class of androgenic hormones. It is a synthetic derivative of dihydrotestosterone (DHT) and has potent anticancer activity against prostate carcinoma cells. Drostanolone enanthate inhibits the growth of cancer cells by binding to the androgen receptor, which is located in the cytoplasm. This causes a conformational change in the receptor that prevents it from interacting with DNA. Drostanolone enanthate also inhibits fatty acid synthesis and microbial biotransformation, which may have anticancer effects.
